Initial Experience of Transabdominal Fetal Reduction in Nepal
- Conditions
- In Vitro Fertilization
- Registration Number
- NCT06251440
- Lead Sponsor
- Grande International Hospital, Nepal
- Brief Summary
Multifetal pregnancies are common in in vitro fertilization. Multifetal gestation increases maternal and fetal morbidity and mortality. We perform fetal reduction in our hospital by intra-thoracic injection of potassium chloride. This manuscript is description of our initial experience.
- Detailed Description
Assisted reproductive technology and stimulated conception have led to an increase in the prevalence of high order multifetal pregnancies (MFPs) in recent times. MFPs are associated with high maternal and fetal complications. Fetal mortality and morbidity are due to complications of prematurity. Prevalence of pregnancy induced hypertension, pre-eclampsia, eclampsia, antepartum hemorrhage, post-partum hemorrhage, gestational diabetes and difficult deliveries are more in mother with MFP. Embryo/Fetal reduction in high order MFPs helps in prolongation of gestation. Multifetal pregnancy reduction (MFPR) is secondary prevention of the risks associated with MFP. Trans-abdominal intracardiac injection of KCl is a simple, safe and effective technique for MFPR. We are among the first few centers in Nepal doing MFPR. In this study, we are sharing our initial experience of the procedure.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 108
- pregnant females with multifetal gestation who opt to undergo fetal reduction
- who do not give consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Transabdominal ultrasonography guided fetal reduction is safe and effective in first trimester 4.5 years To share initial experience of transabdominal multifetal pregnancy reduction (MFPR) in Nepal
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Prajwal Dahal
🇳🇵Kathmandu, Bagmati, Nepal